Camilla Sylvest

Executive Vice President, Commercial Strategy & Corporate Affairs, Novo Nordisk

Camilla Sylvest joined Novo Nordisk in 1996 as trainee. From 1997 to 2008 Ms Sylvest had roles in headquarters and regions within pricing, health economics, marketing and sales effectiveness. In 2003, she was appointed vice president of sales and marketing effectiveness in Region Europe. From 2008 to 2015, Ms Sylvest headed up affiliates and business areas of growing size and complexity in Europe and Asia and in 2013 she was also appointed corporate vice president. In August 2015, Ms Sylvest was appointed senior vice president and general manager of Novo Nordisk’s Region China. In this role she was responsible for the company’s activities in China, Taiwan and Hong Kong. In October 2017, Ms Sylvest was promoted to executive vice president.

Ms Sylvest serves as member of the board of Danish Crown A/S, Denmark.

Ms Sylvest holds an MSc in Economics from University of Southern Denmark and an Executive MBA from Scandinavian International Management Institute.

Ms Sylvest is a Danish national, born November 1972.

Most Popular

Health and Healthcare Systems

人类预期寿命延长,解决肥胖问题对于实现健康老龄化至关重要

人类的预期寿命正在延长,但慢性疾病影响健康,给本就紧张的卫生系统、社区和经济带来压力。肥胖是导致非传染性疾病的主要因素,解决肥胖问题对改善心血管代谢健康和实现健康老龄化至关重要。企业必须采取果断、创新的行动,汇聚政策制定者、健康领袖和行业的力量,遏制超重和肥胖的上升趋势。

17 Mar 2025